Sandler Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$27.4M |
| 2 |
Eaton
ETN
|
+$25.4M |
| 3 |
Hubbell
HUBB
|
+$24.7M |
| 4 |
Datadog
DDOG
|
+$20.7M |
| 5 |
CrowdStrike
CRWD
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marriott International
MAR
|
+$18.5M |
| 2 |
ON Semiconductor
ON
|
+$16.3M |
| 3 |
Charles River Laboratories
CRL
|
+$14.4M |
| 4 |
Broadcom
AVGO
|
+$14.1M |
| 5 |
Welltower
WELL
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 31.59% |
| 2 | Technology | 23.15% |
| 3 | Industrials | 19.75% |
| 4 | Healthcare | 9.06% |
| 5 | Financials | 5.26% |
Similar funds
Sandler Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Sandler Capital Management held 130 positions worth $943M, down 17% from $1.13B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Sandler Capital Management deployed $104M of net new capital in Q2 2022, opening 21 new positions and adding to 33 existing holdings. Its largest new stake was Steris: 121,565 shares worth $25.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Charles River Laboratories, an estimated $14.4M trimmed.
- Sandler Capital Management's largest Q2 2022 buy was Steris: 121,565 shares worth $25.1M.
- Sandler Capital Management added most to Eaton in Q2 2022, an estimated $25.4M increase.
- Sandler Capital Management's biggest Q2 2022 reduction was Charles River Laboratories, cutting an estimated $14.4M.
- Sandler Capital Management fully exited Marriott International in Q2 2022, selling an estimated $18.5M.
- Sandler Capital Management's ten largest holdings make up 32% of its $943M portfolio in Q2 2022.
- Sandler Capital Management opened 21 new positions and closed 39 in Q2 2022.
- Sandler Capital Management's portfolio value fell 17% quarter-over-quarter to $943M.
Based on Sandler Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.